Ultrasound Scoring System for Diagnosis and Prediction of Severity and Surgical Outcomes of Place… (NCT07755709) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Ultrasound Scoring System for Diagnosis and Prediction of Severity and Surgical Outcomes of Placenta Accreta Spectrum
50 participantsStarted 2026-08-04
Plain-language summary
Primary Objective:
To determine the optimal cutoff values of the ultrasound score for different PAS subtypes (no PAS, placenta accreta, placenta increta, and placenta percreta). To evaluate the diagnostic accuracy of the novel Ultrasound Scoring System in predicting the severity of Placenta Accreta Spectrum (PAS) (placenta accreta, increta, and percreta).
Secondary Objective:
* To correlate the novel ultrasound score with intraoperative findings (considered the gold standard) during cesarean delivery, including the degree of placental invasion and the need for surgical interventions (hysterectomy, bladder repair).
* To assess the relationship between the novel ultrasound score and postoperative complications, such as:
* Requirement for hysterectomy
* Bladder or bowel injury
* Blood transfusion requirement
* ICU admission rates
* To explore the potential for integrating the Ultrasound Scoring System with other clinical indicators (e.g., patient age, parity, and history of cesarean sections) to enhance the predictive accuracy for PAS.
Who can participate
Age range
18 Years – 45 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Pregnant women aged 18 to 45 years.
* Gestational age ≥28 weeks at the time of enrollment.
* Diagnosed Placenta Previa with a history of:
* One or more previous cesarean sections
* Uterine scarring due to previous surgery as (myomectomy, D\&C, Metroplasty).
* Singleton pregnancy.
Exclusion Criteria:
* Women with multiple pregnancies (twins, triplets, etc.).
* Pregnancies complicated by acute medical conditions (e.g., heart failure, uncontrolled diabetes).
* Prior history of Blood diseases. (other than those related to pregnancy).
* Women who refuse to participate or withdraw consent during the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
degree of placental invasion and inability to conserve the uterus